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Abstract
Background: Poultry meat is one of the most important sources of human campylobacteriosis, an acute bacterial
enteritis which is a major problem worldwide. Campylobacter coli and Campylobacter jejuni are the most common
Campylobacter species associated with this disease. These pathogens live in the intestinal tract of most avian
species and under commercial conditions they spread rapidly to infect a high proportion of the flock, which makes
their treatment and prevention very difficult. Bacteriophages (phages) are naturally occurring predators of bacteria
with high specificity and also the capacity to evolve to overcome bacterial resistance. Therefore phage therapy is a
promising alternative to antibiotics in animal production. This study tested the efficacy of a phage cocktail
composed of three phages for the control of poultry infected with C. coli and C. jejuni. Moreover, it evaluated the
effectiveness of two routes of phage administration (by oral gavage and in feed) in order to provide additional
information regarding their future use in a poultry unit.
Results: The results indicate that experimental colonisation of chicks was successful and that the birds showed no
signs of disease even at the highest dose of Campylobacter administered. The phage cocktail was able to reduce
the titre of both C. coli and C. jejuni in faeces by approximately 2 log10 cfu/g when administered by oral gavage
and in feed. This reduction persisted throughout the experimental period and neither pathogen regained their
former numbers. The reduction in Campylobacter titre was achieved earlier (2 days post-phage administration)
when the phage cocktail was incorporated in the birds’ feed. Campylobacter strains resistant to phage infection
were recovered from phage-treated chickens at a frequency of 13%. These resistant phenotypes did not exhibit a
reduced ability to colonize the chicken guts and did not revert to sensitive types.
Conclusions: Our findings provide further evidence of the efficacy of phage therapy for the control of
Campylobacter in poultry. The broad host range of the novel phage cocktail enabled it to target both C. jejuni and
C. coli strains. Moreover the reduction of Campylobacter by approximately 2 log10cfu/g, as occurred in our study,
could lead to a 30-fold reduction in the incidence of campylobacteriosis associated with consumption of chicken
meals (according to mathematical models). To our knowledge this is the first report of phage being administered
in feed to Campylobacter-infected chicks and our results show that it lead to an earlier and more sustainable
reduction of Campylobacter than administration by oral gavage. Therefore the present study is of extreme
importance as it has shown that administering phages to poultry via the food could be successful on a
commercial scale.
* Correspondence: jazeredo@deb.uminho.pt
† Contributed equally
1IBB - Institute for Biotechnology and Bioengineering, Centre of Biological
Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga,
Portugal
Full list of author information is available at the end of the article
Carvalho et al. BMC Microbiology 2010, 10:232
http://www.biomedcentral.com/1471-2180/10/232
© 2010 Carvalho et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Background
Worldwide, Campylobacter is recognized as the major
etiologic agent in bacterial human diarrheoal disease
[1-4]. Poultry, particularly chickens, account for the
majority of human infections caused by Campylobacter
[5,6]: Campylobacter jejuni and Campylobacter coli are
the most prevalent species [2,7,8]. Surveys in Europe
revealed that the prevalence of Campylobacter-positive
poultry flocks varies from 18 to 90%, with the northern-
most countries having substantially lower figures than
southern European countries [9]. In the United States a
survey indicated that nearly 90% of flocks were colo-
nized [10]. The prevention of Campylobacter coloniza-
tion has proven to be difficult [11] and therefore control
of Campylobacter in poultry is an especially demanding
goal to attain.
Campylobacter is commonly found in the gastrointest-
inal tract of poultry, where it replicates and colonises
rapidly, even from very low inoculums [2,12]. When
introduced into a flock, infection spreads rapidly by
environmental contamination and coprophagy [9]. The
problem of Campylobacter contamination of poultry is
exacerbated following slaughter by cross-contamination
from Campylobacter-positive to Campylobacter-negative
carcasses during processing in the abattoir [13], showing
that standard biosecurity measures on the processing
plant are ineffective [14]. Even if it were possible to
reduce the level of carcass contamination, such mea-
sures would be costly, difficult to maintain and restric-
tive. Consequently, another strategy is to operate
control measures on the farm and thus significantly
reduce colonization with Campylobacter prior to slaugh-
ter. As yet this has been difficult to achieve: strategies
that successfully reduced Salmonella in broilers have
proved to be only partially effective or totally ineffective
in the control of Campylobacter colonization. These
approaches include the treatment of feed with acid addi-
tives [15], vaccination of breeders [16,17] and competi-
tive exclusion [18,19].
Due to increasing levels of antibiotic resistance in bac-
teria, the European Union has phased out the preventa-
tive use of antibiotics in food production [20].
Therefore, there is a pressing need to find alternatives
to antibiotics that can be used to reduce the numbers of
pathogens in animal products.
Bacteriophages are natural predators of bacteria,
ubiquitous in the environment, self-limiting and self-
replicating in their target bacterial cell [21]. Their high
host-specificity and their capacity to evolve to overcome
bacterial resistance [22] make them a promising alterna-
tive to antibiotics in animal production. There are
several scientific studies on the use of phages to control
animal diseases, namely those caused by Salmonella and
E. coli [11,23-26]. Campylobacter phages have been iso-
lated from several different sources such as sewage, pig
and poultry manure, abattoir effluents, broiler chickens
and retail poultry [27-35]. It has been demonstrated that
they can survive on fresh and frozen retail poultry pro-
ducts [31]. Moreover they can exhibit a control effect
on Campylobacter numbers, even in the absence of host
growth, which is explained by the fact that some phages
adsorb to the surface of the bacteria and just replicate
when the metabolic activity of bacterium increases [36].
These make them potentially an important biocontrol
agent of foodborne diseases.
The present study was undertaken to test the efficacy
of a phage cocktail in reducing the levels of colonization
by both C. coli and C. jejuni in broiler birds. In order to
accomplish this task, experimental models of Campylo-
bacter infection were designed and evaluated prior to
the in vivo phage experiments. Moreover the best
method of administering the phage cocktail was deter-
mined in order to ensure a high and consistent reduc-
tion in Campylobacter colonization. A further objective
of this study was to evaluate the in vivo acquisition of
phage resistance.
Results
Bacteriophage characterization
The phage cocktail used in the present study was com-
posed of three phages (phiCcoIBB35, phiCcoIBB37,
phiCcoIBB12) previously isolated from poultry intestinal
contents and selected on the basis of their broad lytic
spectra against food and clinical C. coli and C. jejuni
strains [35]. The three phages showed different and
complementary lytic spectra [35]. They were morpholo-
gically, genetically and physiologically characterized by
transmission electron microscopy (TEM), pulsed field
gel electrophoresis (PFGE), restriction fragment length
polymorphism (RFLP) and single-step growth experi-
ments. Morphologically the three phages have a similar
structure and size, each possessing an icosahedral head
(average diameter of 100 nm) and a contractile tail (140
× 17 nm average length) with tail fibres at the distal
end. These morphologies are typical of the Myoviridae
family of lytic phages [37]. Electron micrographs are
presented in Figure 1. PFGE and RFLP experiments
showed each of the three phages to have a genomic
DNA size of approximately 200 kb that was not cut by
any of the restriction enzymes tested. Single-step growth
curves results (Figure 2) showed that the burst size of
phage phiCcoIBB35 was 24 pfu with a latent period of
52.5 min; the burst size of phage phiCcoIBB37 was 9
pfu with a latent period of 67.5 min and the burst size
of phage phiCcoIBB12 was 22 pfu with a latent period
of 82.5 min.
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Animal experiments
Campylobacter colonization models
Prior to testing the phage efficacy in vivo it was neces-
sary to determine the optimum dose of Campylobacter
needed to produce consistent Campylobacter levels in
faeces. The essential parameters of the infection model
were therefore set to mimic natural Campylobacter
colonisation: the colonisation level to be between 1 ×
106 and 1 × 109cfu/g of faeces, the number found in
commercial broiler flocks [38], and the birds should be
asymptomatic. The C. jejuni 2140CD1 numbers pre-
sented in Figure 3 show that the geometric mean colo-
nisation level at three days post-infection (dpi) was
lower than at subsequent sampling points. The logarith-
mic mean colonisation levels, excluding 3dpi, were 2.2,
1.1, and 5.8 × 106cfu/g for the low, medium and high
dose groups respectively and the standard error of the
mean was approximately 0.3 cfu/g. The primary reason
for the lower mean in the 3dpi sample point was that
within each group some of the samples were negative
for C. jejuni 2140CD1, which reduced the mean levels:
four out of seven birds in the low dose group, one out
of seven birds in the medium dose group and three out
of seven birds in the high dose group were negative.
These negative samples were represented by birds that
were not colonized or birds which the Campylobacter
numbers in faecal samples was inferior to the detection
limit (500 cfu/g). Similar experiments were performed
to establish the colonization model for the C. coli strain
used in this study (C. coli A11) and a consistent number
of 1.7 × 106cfu/g bacterial cells was found in the faeces
of the birds after 7dpi.
Phage cocktail administration
Prior to the phage cocktail administration experiments,
all birds were screened for phages active against the
inoculum Campylobacter and proved to be negative.
In a preliminary experiment (data not shown), the
phage cocktail was administrated by oral gavage to one-
week old chicks infected with C. jejuni 2140CD1. The
faecal samples collected at all sample time points pre-
sented Campylobacter but did not contain any of the
phages administered. This suggested that the phages
might have been sensitive to low pH such as occurs
during passage through the proventriculus and gizzard.
The use of an antacid has been demonstrated to
improve the ability of phages to survive low acidity in
the digestive system [39] and therefore in the following
trials (Experiment 1 and Experiment 2) the phage cock-
tail was administered with CaCO3.
In Experiments 1 and 2 the results show that the
numbers of Campylobacter in the control group were
stable throughout the experiments (no statistically sig-
nificant difference), which shows that the birds were
well colonized. Moreover the fact that the treated
groups and the untreated groups had the same level of
Campylobacter colonization at the beginning of the
experiments ensures that accurate comparisons between
these two groups can be made.
In Experiment 1, the phage cocktail was administered
by oral gavage to one-week old chicks infected with C.
jejuni 2140CD1. In order to determine the best phage
delivery policy, in Experiment 2 a comparison was made
of administering the phage cocktail by oral gavage and
by incorporating it into the chicks’ food, using chicks
infected with C. coli A11.
For Experiments 1 and 2, the data show a reduction
in the number of Campylobacter in the chicks that
received the phage cocktail when compared to the
chicks from the untreated group (control group) which
received only antacid (Figures 4 and 5 respectively).
The log10cfu/g difference between these groups is pre-
sented in Table 1. After phage administration, the colo-
nization values from the chicks belonging to the treated
groups were lower than the values from the chicks that
received no treatment (control group). In fact, using
one-way ANOVA, it can be said that each value of
Figure 1 Electron micrographs of the Campylobacter phages that composed the cocktail: (a) Phage phiCcoIBB12; (b) Phage
phiCcoIBB35; (c) Phage phiCcoIBB37. Phages were stained with 1% uranyl acetate and observed with a transmission electron microscopy.
There was no difference in morphology between the three phages. They have an icosahedral head of approximately 100 nm in diameter and a
contractile tail with 140 × 17 nm average length. This morphology is typical of the members of the Myoviridae family.
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Campylobacter counts from the treated and the control
group was statistically significant different (P < 0.05)
during the experimental period. In Experiment 1, at
four days post-phage administration (4 dpa) it was
already possible to see a reduction of 2.34 log10 cfu/g
in the numbers of C. jejuni 2140CD1 when comparing
the untreated and treated groups. This reduction was
consistent through the experiment and at 7 dpa it was
2.18 log10cfu/g. In Experiment 2 the results show that
phage cocktail delivered by food was effective and
resulted in a slightly higher reduction (approximately 2
log10 cfu/g) in pathogen numbers than the phage cock-
tail administered by oral gavage (1.7 log10 cfu/g reduc-
tion), when compared to the untreated group at the
end of the experimental period (7 dpa). However a
reduction of 2 log10 cfu/g in Campylobacter numbers
in faeces was already observed at 2 dpa when the phage
cocktail was given by food, while at this time point the
reduction was only 1.25 log10 cfu/g in the faecal sam-
ples of the group that received the phage cocktail by
oral gavage. We believe that this trial was not compro-
mised by the pecking order of the chickens because the
birds were observed during the trial in order to assure
that all of them had eaten. Moreover the low value of
the standard error (0.2 pfu/g) of the phage titer after
two days of treatment demonstrated that there were
small variations in the dose of phage that each bird
received.
The phage titers from faecal samples of the chicks
infected with C. jejuni and C. coli were log10 5.3 pfu/g
and log10 3.4 pfu/g for Experiment 1 and Experiment 2
respectively. These values remained approximately con-
stant throughout the experimental period showing that
phages delivered to chicks (either by oral gavage or in
feed) were able to replicate and therefore able to reduce
the Campylobacter populations.
Previous studies [40,41] have used the number of
Campylobacter in the caecal contents of the birds as a
measure of Campylobacter colonisation levels in the GI
tract of chickens [41,34]. Although this may be a repre-
sentative of colonisation levels, the animals must be
killed and dissected to obtain the sample. This can lead
to the use of an excessive number of birds when multi-
ple time points are required to evaluate phage levels
over the lifetime of the bird. Therefore in the present
study cloacal swabs were used to determine colonisation
levels as they can provide a rough estimate of the num-
bers of bacteria in the cecum of chickens [42]. Moreover
these samples show the kinetics of colonization as mul-
tiple samples can be taken from single birds. Another
advantage is that it represents the number of Campylo-
bacter being released from the bird into the environ-
ment and so directly correlates to the capacity of the
bird to transmit the bacteria.
Figure 2 Single-step growth curve of the Campylobacter
phages that composed the cocktail: (a) Phage phiCcoIBB35; (b)
Phage phiCcoIBB37; (c) Phage phiCcoIBB12. Single-step growth
experiments were performed in order to assess the latent period
and burst size of a single round of phage replication: phage
phiCcoIBB35 has a burst size of 24 pfu and a latent period of 52.5
min; phage phiCcoIBB37 has a burst size of 9 pfu and a latent
period of 67.5 min; phage phiCcoIBB12 has a burst size of 22 pfu
and a latent period of 82.5 min. Samples were taken every 15 min
for 4 h. The data was fitted to a four-parameter symmetric sigmoid
model. Non-linear regression was performed to calculate the latent
period and burst size. Error bars represent the standard deviation.
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In vivo acquisition of phage resistance
In order to evaluate the acquisition of resistance to the
phage cocktail in Campylobacter jejuni infected and
treated birds, a total of 300 Campylobacter colonies, iso-
lated from each infected bird belonging to the treated
group in Experiment 1, were checked for their sensitiv-
ity to the phage cocktail, before and after phage admin-
istration. We observed that before phage treatment, 6%
of the isolated colonies were resistant to the phage and
at 7 dpa 13% of the isolated colonies were phage resis-
tant. Although the results from these experiments are
not easily interpreted because bacteria that had not
been exposed to phage already demonstrated a certain
degree of phage resistance, the key conclusion is that
the resistant phenotype could have been selected for
during therapy. If that was the case, then the resistant
phenotype would soon become the dominant phenotype
after therapy began. This may be connected to previous
observations that resistant bacteria lose fitness and are
out-competed by the non-resistant phenotype in the
intestines, despite being sensitive to the phage that is
present [40]. To test this hypothesis seven groups of 15
birds were inoculated with phage-sensitive and phage-
resistant Campylobacter strains re-isolated from birds
used in the previous trial. The numbers of Campylobac-
ter in faeces from each bird was enumerated at seven
days post-inoculation (Table 2). There was no significant
difference between any of the groups (P > 0.05 by
t-test). This suggests that the resistant phenotype was
not hindering the ability of the Campylobacter to colo-
nise the chickens. However it may have been the case
that in vivo the resistant phenotype was rapidly lost so
no lack of fitness was evident. In order to test this
hypothesis we randomly selected three Campylobacter
colonies from faecal samples from each infected chicken
of each of the groups and determined their sensitivity to
the phage cocktail (Table 2). Interestingly, 86.2% of the
colonies isolated from chickens infected with resistant
strains isolated before phage treatment lost their resis-
tant phenotype and 54% of the resistant strains isolated
in phage treated chickens reverted their resistant pheno-
type to a sensitive one. These results are not in accor-
dance with Loc Carrillo et al. [40] in which 97% of
resistant phenotype reverted back to phage sensitive
strains.
Discussion
The characterization of the three Campylobacter phages
that compose the cocktail is in accordance with the
majority of Campylobacter phages reported in the litera-
ture [29,31,34,40,43,44]. The only restriction enzyme
that has been used successfully to digest the DNA of
some Campylobacter phages is HhaI, but even this
enzyme did not yield results for the phages used in the
present study. Possible explanations for these results
include: the phage genomes may have lost restriction
Figure 3 Colonization of chicks by Campylobacter jejuni 2140CD1 after challenge with a range of dose levels. Eighteen, one day-old
chicks were randomly assigned to one of three groups receiving by oral gavage different concentrations of 0.1 ml of PBS C. jejuni 2140CD1:low
dose (7.5 × 104cfu); medium dose (1.0 × 106cfu) and high dose (5.5 × 107cfu). Faecal samples were collected from all birds at intervals and
Campylobacter and phages enumerated. Error bars represent the standard error of the mean.
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sites due to selective pressures from restriction modifi-
cation systems; the phage genomes may have encoded
nucleotide-modifying enzymes such as methyltrans-
ferases that would have modified the bases at the
restriction sites; the phage genomes may contain unu-
sual bases. Further studies such as phage genome
sequencing would be needed in order to understand the
refractory nature of the DNA of the Campylobacter
phages.
To our knowledge there is just one report in the lit-
erature where the burst size and latent period para-
meters were calculated for Campylobacter phages, i.e.
1.957 virions per cell and 1.312 h respectively [45]. The
phages phiCcoIBB35, phiCcoIBB37 and phiCcoIBB12
that were used in the present study have smaller latent
periods (52.5 min, 67.5 min and 82.5 min) and higher
burst sizes (24, 9 and 22 virions per cell) respectively.
In order to evaluate the efficacy of the three phages in
the in vivo trials, it was necessary to recreate experimen-
tally Campylobacter colonization in chicks. The model
used revealed a successful colonisation; no birds in any
of the groups showed any overt symptoms of disease,
colonisation or stress even at the highest dose of Cam-
pylobacter administered. This asymptomatic carriage
mimics Campylobacter colonisation in commercial
flocks. The dose of Campylobacter appeared to have lit-
tle effect on the outcome of subsequent colonisation
levels. The logarithmic mean level of colonisation of the
three groups was 2.4 × 106cfu/g, which is within the
range of the infection levels found in commercial broiler
Figure 4 Numbers of Campylobacter jejuni 2140CD1 (a) and phages (b) in faeces from broilers orally administered a phage cocktail by
gavage. Thirty day-old chicks were inoculated with Campylobacter jejuni 2140CD1. One week later the birds were randomly assigned to a
treated group or an untreated group and were inoculated by oral gavage with antacid containing 1 × 106pfu of a phage cocktail, or antacid
only respectively. Faecal samples were collected from all birds at intervals and Campylobacter and phages enumerated. Error bars represent the
standard error of the mean. At 2 dpa, 4 dpa and 7 dpa there is a significant difference between control and infected group at P < 0.05.
Figure 5 Numbers of Campylobacter coli A11 (a) and phages (b) in faeces from broilers orally administered phage by food or by oral
gavage. Forty-five, day-old chicks were inoculated with Campylobacter coli A11. One week later the birds were randomly assigned to one of
three groups, a non-treated group and two treated groups: a group receiving the phage cocktail by oral gavage; and a group receiving the
phage cocktail in feed. Birds were inoculated with antacid only, antacid containing 1 × 106pfu phage cocktail or antacid followed by feeding
with the phage cocktail laced with 1.5 × 107pfu, respectively. Faecal samples were collected from all birds at intervals and Campylobacter and
phages enumerated. Error bars represent the standard error of the mean. At 1 dpa, 2 dpa, 4 dpa and 7 dpa there is a significant difference
between control and infected groups at P < 0.05.
Carvalho et al. BMC Microbiology 2010, 10:232
http://www.biomedcentral.com/1471-2180/10/232
Page 6 of 11
flocks: 1 × 106 to 1 × 109cfu/g [38] and hence is an
appropriate level for the experimental model. The data
shows that Campylobacter had not consistently colo-
nised all the birds by 3dpi. Although the reasons for
Campylobacter colonization failure of young birds are
still unclear, these negative colonized chickens may have
maternal antibodies which protects them from Campylo-
bacter colonization [46]. In all subsequent time points
all birds were colonised. This suggests that if a trial is to
evaluate the reduction of Campylobacter levels from
colonised birds, it is essential to allow time for Campy-
lobacter to become established in the gut of the chicks
before phage treatment is initiated. Therefore, in the
present study phage treatment was performed after
seven days post-infection.
The results of the in vivo trials show that the phage
cocktail was able to reduce the number of C. jejuni
(Experiment 1) and C. coli (Experiment 2) colonisation
in chickens, by approximately 2 log10 cfu/g. Moreover
this reduction persisted throughout the experimental
period. Other studies [40,41] produced a similar reduc-
tion of Campylobacter counts at the end of the experi-
mental period. However that reduction was of transient
nature in comparison to our study, where a sustained
reduction in Campylobacter numbers was obtained dur-
ing the seven days trial. A phage therapy that produces
this kind of reduction of a pathogen would probably
allow the phage administration to the birds at any point
in the production cycle. The advantages of giving the
phage early in production would be that environmental
contamination would be minimised and that only a
proportion of the flock would need treating as the
phage would be spread naturally in the environment to
all birds. However this strategy does carry a risk of resis-
tance emerging and reducing the efficacy of treatment.
In fact, Campylobacter strains resistant to phage infec-
tion were recovered from phage-treated chickens at a
frequency of 13%. However resistance to the phage
cocktail was found in Campylobacter in chickens before
phage therapy, which means that bacteria can naturally
acquire phage resistance. Nevertheless, following phage
treatment an increase in the resistant population was
observed meaning that phages might have selected for
resistant strains. In our results and conversely to results
described by Loc Carrillo et al. [40] the resistant pheno-
type did not lose the ability to colonise the chicken gut
and did not completely revert to sensitive type. This can
be pointed out as a major drawback of phage therapy.
So, in order to overcome this problem the best strategy
of phage administration is a short time before slaughter.
Additionally, it is recommended that when selecting the
phages that will compose the cocktail an additional cri-
terion should be the ability to infect other phage resis-
tant Campylobacter phenotypes.
In the present study, two phage administration strate-
gies were assessed: oral gavage and food incorporation.
Oral gavage permitted the delivery of accurate doses
directly to the gastro-intestinal (GI) tract of individual
birds. However if phage therapy is to be utilised by the
poultry industry then the phage product must be simple
and cheap to administer to flocks consisting of several
thousand birds. We demonstrated that application of
phage therapy can be successfully achieved in food lead-
ing to a reduction similar to that achieved by oral
gavage. Moreover this reduction was earlier in compari-
son to the group that received the phage cocktail by
oral gavage which can be explained by the protective
effect of food that hampers the low pH from inactivat-
ing the phages [47]. These results are of extreme impor-
tance as this route of phage administration can provide
a viable strategy for delivery of phage in a commercial
context. Phages could also be given in the drinking
water, however preliminary experiments showed that
phage needed to be administrated with antacid and this
could prove more difficult to deliver with the water than
as an inclusion in the feed.
Moreover, in our study the phage cocktail was admi-
nistered as a single dose to Campylobacter-infected
chicks 7dpi. A single dose of phage is, in comparison to
multiple doses [41], an easier and more feasible strategy
in a farm situation.
It must be noted that the present model does not
comprise all the variables that can play a role in the use
of phages to control Campylobacter in poultry. Firstly,
this model considers the use of phages as a therapy and
Table 1 Difference between the geometric means of the
Campylobacter titre from broilers with and without the
phage cocktail administration
Experiment Administration
route
Campylobacter titre (log10cfu/g)
Day 2 Day 4 Day 7
Experiment 1 Oral Gavage 1.74 2.34 2.18
Experiment 2 Oral Gavage 1.25 1.58 1.69
Feed 2.00 1.45 1.96
Table 2 Geometric means of Campylobacter titre
(log10cfu/g) in faeces of broilers after 7 dpi with phage
sensitive and phage resistant Campylobacter strains; (%)
of resistant Campylobacter strains to the phage cocktail
Campylobacter phage
sensitivity
Campylobacter titre
(log10cfu/g)
Resistant
strains
(%)
Sensitive 6.55 nd
Resistant (a)* 6.50 13.8
Resistant (b)* 6.29 46
*(a) Strains isolated from non-phage treated chickens and (b) Strains isolated
from phage treated chickens
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not as a prophylactic measure. Secondly, in the present
work birds were challenged with Campylobacter at one-
year-old, but in a real commercial context birds just get
colonized with Campylobacter after two weeks of age.
However, these conditions were not tested in our
experiments as it is very difficult to maintain chicks free
of pathogens. An additional limitation of the model was
the limited time course of the experiments (seven days).
Nevertheless, the model described herein is a proof of
principle that Campylobacter phages given orally or
administered in feed can effectively reduce the Campylo-
bacter colonization levels. Further studies need to be
undertaken in order to test phage effectiveness in older
chickens, their use as prophylactic agents and longer
time course trials in order to reflect the production
cycle.
Conclusions
The phage cocktail was able to reduce C. coli and C.
jejuni in infected poultry by approximately 2 log10cfu/g,
which is of great importance as they are the most preva-
lent Campylobacter species found in positive Campylo-
bacter flocks. Moreover mathematical models indicate
that a 2 log10cfu/g reduction of Campylobacter on the
chicken carcasses could lead to a 30-fold reduction in
the incidence of campylobacteriosis associated with con-
sumption of chicken meals [48]. The phage cocktail
administered in feed led to an earlier reduction in Cam-
pylobacter titre than when given by oral gavage and
thus this method can be easily and successfully used
under commercial condition in a poultry unit. Another
important aspect of the present study is that as the
phages that composed the cocktail were isolated from
poultry carcasses, their use to reduce Campylobacter
colonisation in the live birds would not introduce any
new biological entity into the food chain.
Methods
Bacterial strains
For the single-step growth experiments, two wild type
strains of C. coli, isolated from poultry and poultry pro-
ducts, were used as the hosts of the three phages that
composed the cocktail (C. coli A11, host of phages
phiCcoIBB35 and phiCcoIBB37; C. coli 8907, host of
phage phiCcoIBB12). For the animal trials, two Campy-
lobacter strains were chosen: C. coli A11 and C. jejuni
2140CD1 (isolated from chickens in a commercial pro-
duction unit).
Bacteriophage characterization
For the phage cocktail, three phages (phiCcoIBB35,
phiCcoIBB37, phiCcoIBB12) were selected from a panel
of 43 phages, isolated from poultry carcasses, based on
their broad lytic spectra against C. coli and C. jejuni
strains [35]. These phages were characterized by trans-
mission electron microscopy (TEM), pulsed field gel
electrophoresis (PFGE), restriction fragment length poly-
morphism (RFLP) and single-step-growth experiments.
TEM characterization
PEG-purified phage samples were applied for 1 min on
glow-discharged 400-mesh Formvar Carbon copper
grids (Ted Pella) and blot dried. The grids were stained
with 1% uranyl acetate for 1 min. The samples were
observed under a JEOL transmission electron micro-
scope at 60 kV and images recorded (Figure 1).
PFGE
Phage DNA was extracted using the SDS-proteinase K
protocol described by Sambrook and Russell [49] for
lambda phage. The PFGE determination was performed
as described by Lingohr and Johnson [50].
Restriction Profile
Restriction endonuclease digests was performed using
the following enzymes: HhaI, EcoRV, EcoRI, XbaI, Hin-
dIII, DdeI in accordance to the manufacturer’s instruc-
tions i.e. 1 h at 37°C (Fermentas Life Sciences).
Electrophoresis of the digested DNA was performed at
90 V for 2 h using 1.5% agarose Tris-acetate-EDTA gel.
Burst size and Latent Period (Single-step growth curve)
Single-step growth experiments were performed in order
to assess the latent period and burst size of a single
round of phage replication. Briefly, host cells were
grown to early exponential phase (OD600 nm = 0.3) in
100 ml of NZCYM broth (Sigma Aldrich, Poole, UK)
and incubated with shaking at 42°C in a microaerobic
atmosphere (5% O2, 5% H2, 10% CO2, 80% N2). They
were then infected with the particular phage at a multi-
plicity of infection (MOI) of 0.001. Samples were taken
every 15 min for 4 h and the titre determined immedi-
ately by the double-layer agar plate method in NZCYM
agar (NZCYM broth with 1% agar (Sigma Aldrich).
Three independent replicates of each single-step growth
experiment were performed. The mean values obtained
from these experiments are presented on Figure 2. The
data were fitted to a four-parameter symmetric sigmoid
model. Non-linear regression was performed to calculate
the latent period and burst size.
Animal experiments
The animal experiments were designed to obtain suffi-
cient high quality data to achieve objectives whilst con-
serving available resources including animals, money,
work hours and consumables. Therefore all animal
experiments were carried out according to the UK Ani-
mals (Scientific procedures) Act 1986 (licence number
PPL 30/2322), which stipulates that any experiments on
live animals requires a justification of numbers used to
ensure that meaningful data is gathered from the least
number of animals.
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One-day-old Ross broiler chicks (Faccenda, Brackley,
UK) were obtained from a commercial hatchery and
were housed in a controlled environment in floor boxes
under strict biosecurity. Swabs of faecal samples were
collected from each individual bird prior to the experi-
ment starting to ensure the absence of any Campylobac-
ter and any phages against the Campylobacter strains
which were used for infection. Faecal samples were then
pooled in groups of six and 1 g inoculated into 10 ml of
Bolton broth (Oxoid, Basingstoke, UK) supplemented
with cefaperazone, vancomycin, trimethoprim and cyclo-
heximide (Oxoid) and 5% lysed horse blood (Oxoid).
The broths were incubated at 42°C in a microaerobic
atmosphere overnight and then plated onto mCCDA
(Oxoid) and incubated in the same manner for 48 h.
Plates were then checked for growth of Campylobacter.
The screen for phages was performed using the ‘phage
detection using semi-solid agar’ methodology detailed
below.
Colonization model
Three groups of six birds, designated low, medium and
high dose were used: each group received a crop gavage
of 0.1 ml of PBS (Sigma) containing respectively 7.5 ×
104, 1.0 × 106, or 5.5 × 107cfu of an overnight culture
(42°C in microaerobic atmosphere) of C. jejuni strain
2140CD1. Swabs of faecal samples were collected from
each individual bird at 3, 7, 10, 14, and 17 dpi (days
post-infection). Campylobacter enumeration was per-
formed by serial ten-fold dilutions in SM buffer (0.05
mol/l Tris-HCl [pH 7.5], 0.1 mol/l NaCl, 0.008 mol/l
MgSO4) followed by plate counts on mCCDA plates
(Oxoid). The same experiments were performed with
the C. coli A11, with the exception that only the med-
ium dose of inocula (1.0 × 106cfu) was used to infect
the chicks.
Phage cocktail administration
Two animal experiments were conducted. In Experi-
ment 1, thirty one-day-old chicks were inoculated with
1 × 106cfu of C. jejuni 2140CD1 in 0.1 ml PBS by oral
gavage and housed together for seven days. One week
later faecal samples were collected to screen for phage
active against the Campylobacter strain in the inocula
using the ‘phage detection using semi-solid agar’ metho-
dology detailed below. The chicks were then randomly
divided into groups of 15 and inoculated with 1 ×
106pfu of the phage cocktail in 1 ml of antacid (30%
CaCO3), or given antacid only (control group). In
Experiment 2, C. jejuni 2140CD1 was substituted for C.
coli A11 and two methods of phage administration were
compared: oral gavage and in food. The administration
in feed was achieved by withdrawing the normal feed
for 3 h and then dosing the chicks with 1 ml of antacid.
The group of chicks were then given 45 g of chick
crumbs laced with 1.5 × 107pfu phage cocktail in 1.5 ml
of SM buffer. After all of the food had been consumed
(~1 h) normal feed was re-introduced. Birds were
observed during this feeding period to ensure they had
all fed. Swabs of faecal samples were collected from
each individual bird at intervals after the phage cocktail
had been administered and Campylobacter and phages
enumerated. The samples were weighed and nine
volumes of SM buffer added to produce a 1/10 faecal
suspension (minimum of 1.5 ml of SM buffer was
added).
Campylobacter enumeration
A ten-fold dilution series in 10 mM MgSO4 was pre-
pared from each faecal sample collected and 20 μl ali-
quots of each dilution were spread on half plates of
mCCDA agar (Oxoid). The plates were incubated at 42°
C in a microaerobic atmosphere for 48 h and character-
istic Campylobacter colonies were counted to determine
the titre in the original faecal sample.
Phage detection using semi-solid agar
Cultures of C. jejuni 2140CD1 or C. coli A11 were
streaked on 5% horse blood agar (Oxoid) and incubated
overnight at 42°C in a microaerobic atmosphere. The
bacteria were harvested into 1.5 ml of 10 mM MgSO4,
and added to 50 ml of molten (55°C) ‘top agar’:
NZCYM broth (BD Biosciences, Oxford, UK) with 0.7%
Agar (BD Biosciences).
For screening the pooled faecal samples, a semi-solid
overlay method was used: the molten agar and the tar-
get Campylobacter strain suspension (approximately 5
ml) was poured onto an NZCYM plate and allowed to
set. The pooled faecal samples were treated with 20%
(w/v) chloroform, vortexed and then centrifuged at 8600
g for 5 min. Each supernatant was then applied to the
over-layered plates in a 20 μl drop. Plates were then
incubated at 42°C in a microaerobic atmosphere. For
enumeration of phage, a ten-fold dilution series was pre-
pared from each treated sample and a 20 μl aliquot
placed in (the centre of) one well of a 6-well tissue cul-
ture plate. Three ml of the suspension of Campylobacter
and molten agar was then added to each well, gently
mixed and then the plates were incubated at 42°C in a
microaerobic atmosphere overnight. Plaques in the bac-
terial lawn were counted after incubation and the phage
titre determined.
In vivo acquisition of phage resistance
Swabs of faecal samples were collected from birds colo-
nized with Campylobacter jejuni strain 2140CD1 at 0
dpa and at 7 dpa in Experiment 1. A ten-fold dilution
series in 10 mM MgSO4 was prepared from each faecal
sample collected and 20 μl aliquots of each dilution
were spread on half plates of mCCDA agar (Oxoid).
The plates were incubated at 42°C in a microaerobic
atmosphere for 48 h and ten characteristic Campylobac-
ter colonies were randomly selected from each faecal
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sample and their sensitivity to the phage cocktail was
tested. Briefly, a drop of the phage cocktail (10 μ) was
added to lawns [35] of each colony pick and the plates
incubated overnight at 42°C in microaerobic atmo-
sphere. The appearance of clear zones around the point
of application was recorded as the ability to lyse that
strain.
Seven groups of 15 birds were inoculated with 0.1 m
of PBS containing 1.0 × 106cfu of an overnight culture
(42°C in microaerobic atmosphere) of the Campylobac-
ter jejuni strains re-isolated from birds used in the pre-
vious trial: two groups received one of each of two
separate sensitive Campylobacter strains, three groups
received the Campylobacter resistant strains isolated
from treated birds and finally two groups received the
resistant Campylobacter isolated from birds before
phage treatment. The numbers of Campylobacter in
faeces from each bird was enumerated at seven days
post-inoculation. Swabs of faecal samples were collected
from the infected birds and three Campylobacter colo-
nies isolates were selected at random from each faecal
sample and checked for their sensitivity to the phage
cocktail, as previously described.
Statistical treatment of data
Statistical differences in faecal samples between control
and the phage cocktail treatment groups, between the
phage cocktail treatment groups themselves and
between the sampling points within each group were
assessed by using the one-way ANOVA test.
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